Lucid Diagnostics Inc (LUCD) Provides Business Update, Reports Prelim Q4
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- HubSpot to cut 7% of workforce in restructuring plan
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Caribou Biosciences to halt CAR-T programs, explore sale
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
Lucid Diagnostics Inc (LUCD) PT Lowered to $12 at Canaccord Genuity
March 29, 2022 7:40 AM EDTCanaccord Genuity analyst Kyle Mikson lowered the price target on Lucid Diagnostics Inc (NASDAQ: LUCD) to $12.00 (from $18.00) while maintaining a Buy rating.
... MoreLucid Diagnostics Inc (LUCD) PT Lowered to $7 at Needham & Company
March 29, 2022 6:31 AM EDTNeedham & Company analyst Mike Matson lowered the price target on Lucid Diagnostics Inc (NASDAQ: LUCD) to $7.00 (from $13.00) while maintaining a Buy rating after the company missed fourth-quarter revenue consensus.
The analyst commented, "LUCD missed consensus revenue in 4Q21. EsoGuard test volume grew 49% sequentially... More



